Melanoma is considered a fatal type of skin cancer. However, it is sometimes hard to distinguish it from nevus due to their identical visual appearance and symptoms. The mortality rate because of this disease is higher than all other skin-related consolidated malignancies. The number of cases is growing among young people, but if it is diagnosed at an earlier stage, then the survival rates become very high. The cost and time required for the doctors to diagnose all patients for melanoma are very high. In this paper, we propose an intelligent system to detect and distinguish melanoma from nevus by using the stateof-the-art image processing techniques. At first, the Gaussian filter is used for removing noise from the skin lesion of the acquired images followed by the use of improved K-mean clustering to segment out the lesion. A distinctive hybrid superfeature vector is formed by the extraction of textural and color features from the lesion. Support vector machine (SVM) is utilized for the classification of skin cancer into melanoma and nevus. Our aim is to test the effectiveness of the proposed segmentation technique, extract the most suitable features, and compare the classification results with the other techniques present in the literature. The proposed methodology is tested on the DERMIS dataset having a total number of 397 skin cancer images: 146 are melanoma and 251 are nevus skin lesions. Our proposed methodology archives encouraging results having 96% accuracy. INDEX TERMS Melanoma, nevus, feature, K-means clustering, and centroid selection.
Alzheimer’s disease effects human brain cells and results in dementia. The gradual deterioration of the brain cells results in disability of performing daily routine tasks. The treatment for this disease is still not mature enough. However, its early diagnosis may allow restraining the spread of disease. For early detection of Alzheimer’s through brain Magnetic Resonance Imaging (MRI), an automated detection and classification system needs to be developed that can detect and classify the subject having dementia. These systems also need not only to classify dementia patients but to also identify the four progressing stages of dementia. The proposed system works on an efficient technique of utilizing transfer learning to classify the images by fine-tuning a pre-trained convolutional network, AlexNet. The architecture is trained and tested over the pre-processed segmented (Grey Matter, White Matter, and Cerebral Spinal Fluid) and un-segmented images for both binary and multi-class classification. The performance of the proposed system is evaluated over Open Access Series of Imaging Studies (OASIS) dataset. The algorithm showed promising results by giving the best overall accuracy of 92.85% for multi-class classification of un-segmented images.
Alzheimer's Disease (AD) is the most common form of dementia. It gradually increases from mild stage to severe, affecting the ability to perform common daily tasks without assistance. It is a neurodegenerative illness, presently having no specified cure. Computer-Aided Diagnostic Systems have played an important role to help physicians to identify AD. However, the diagnosis of AD into its four stages; No Dementia, Very Mild Dementia, Mild Dementia, and Moderate Dementia remains an open research area. Deep learning assisted computer-aided solutions are proved to be more useful because of their high accuracy. However, the most common problem with deep learning architecture is that large training data is required. Furthermore, the samples should be evenly distributed among the classes to avoid the class imbalance problem. The publicly available dataset (OASIS) has serious class imbalance problem. In this research, we employed a transfer learning-based technique using data augmentation for 3D Magnetic Resonance Imaging (MRI) views from OASIS dataset. The accuracy of the proposed model utilizing a single view of the brain MRI is 98.41% while using 3D-views is 95.11%. The proposed system outperformed the existing techniques for Alzheimer disease stages.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations –citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.